Fathom Therapeutics
PrivateLast Round
Series A
Apr 27, 2026
Total Funding Raised
$54.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Fathom Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in April 2026.
Fathom Therapeutics is a biotechnology company that uses physics-based simulations and AI to model protein motion and interactions at atomic resolution for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fathom Therapeutics Comparables
Compare Fathom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PsiThera | 90% | |
| Redesign Science | 89% | |
| Iambic Therapeutics | 86% |
For institutional investors. Book with your work email.
Fathom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 27, 2026 | ||||
| Early Stage VC | Mar 6, 2026 | ||||
| Seed | Nov 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fathom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemistry VC | Series A |
| Alexandria Venture Investments | Series A |
| New York Ventures | Series A |
| Sutter Hill Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jun 19, 2026
Monthly visitors increased 81% MoM.
For institutional investors. Book with your work email.
Fathom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fathom Therapeutics's valuation, stock price, and market status.
Is Fathom Therapeutics a public or private company?
Fathom Therapeutics is a private company.
What is the current stock price of Fathom Therapeutics?
Fathom Therapeutics is a private company, so its shares have no public market price. Caplight tracks Fathom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fathom Therapeutics worth (valuation)?
Valuation information for Fathom Therapeutics is not publicly available.
Can I buy Fathom Therapeutics stock?
Fathom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fathom Therapeutics's last funding round?
Fathom Therapeutics's most recent funding round was Series A on April 27, 2026.
Who are the main investors in Fathom Therapeutics?
Key investors in Fathom Therapeutics include Sutter Hill Ventures.
Will Fathom Therapeutics IPO soon?
No public IPO plans have been announced for Fathom Therapeutics.
How can I track Fathom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Fathom Therapeutics's shares on secondary markets.